• Explore /
  • Poster
  • / Nonclinical evaluation of the combination of mouse IL-21 and anti- mouse CTLA-4 or PD-1 blocking antibodies in mouse tumor models.

Nonclinical evaluation of the combination of mouse IL-21 and anti- mouse CTLA-4 or PD-1 blocking antibodies in mouse tumor models.

Abstract Poster

Authors

null

Maria Jure-Kunkel

Bristol-Myers Squibb, Princeton, NJ

Maria Jure-Kunkel , Mark Selby , Katherine Lewis , Gregg Masters , Jose Valle , Joseph Grosso , Gennaro Dito , Wendy Curtis , Richard Garcia , Matthew Holdren , Alan J. Korman , Stacey Dillon

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Developmental Therapeutics - Immunotherapy

Track

Developmental Therapeutics

Sub Track

Immunotherapy and Biologic Therapy

Citation

J Clin Oncol 31, 2013 (suppl; abstr 3019)

DOI

10.1200/jco.2013.31.15_suppl.3019

Abstract #

3019

Poster Bd #

11

Abstract Disclosures

Similar Posters

First Author: Ari M. Vanderwalde

First Author: Mark Selby

First Author: Guillermo De Velasco

First Author: Kimberly Loo